Nippon India Pharma Fund - Direct Plan - Growth Plan
Add To Comparepreviously known as Reliance Pharma Dir Gr until
NAV on April 24, 2024
Category
Equity:
Sector - Healthcare
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets
7,125 cr
Turnover Ratio
18.67%
Expense Ratio
0.92%
Exit Load
1.00%
if redeemed within
Returns
- 1M: -0.25%
- 1Y: 52.08%
- 3M: 3.00%
- 3Y: 16.71%
- 6M: 24.05%
- 5Y: 23.48%